Article
Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) - 1 Aug 2023
Tsakonas Georgios, Tadigotla Vasisht, Chakrabortty Sudipto K, Stragliotto Giuseppe, Chan Dalin, Lewensohn Rolf, Yu Wei, Skog Johan K, Hydbring Per, Ekman Simon
Abstract excerpt
OBJECTIVES: Non-small cell lung cancer (NSCLC) with brain metastases (BM) is a challenging clinical issue with poor prognosis. No data exist regarding extensive genetic analysis of cerebrospinal fluid (CSF) and its correlation to associated tumor compartments. MATERIALS AND METHODS: We designed a study across multiple NSCLC patients with matched material from four compartments; primary tumor, BM, plasma and CSF....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
